Association between duration of diabetes and fasting lipid profile in Bangladeshi type-2 diabetic patients: a series of hundred one cases
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20251683Keywords:
Duration, Patients, Association, Fasting, Lipid profile, Type 2 diabetesAbstract
Background: Type 2 diabetes mellitus is a growing global health problem, with its prevalence rising significantly in developing nations. This chronic metabolic condition is characterized by persistent hyperglycemia and is strongly associated with dyslipidemia, a prime risk factor for cardiovascular diseases (CVD). The aim of this study was to evaluate the association of the length of type 2 diabetes with fasting lipid profiles of the type 2 diabetic patients.
Methods: This cross-sectional descriptive type of study was carried out at the Department of Laboratory Medicine, Epic Health Care Limited, in Chattogram, Bangladesh, from December 2023 to May 2024. A total of 101 type 2 medicated diabetic cases were employed in this study. The data were analyzed using Statistical Package for Social Sciences (SPSS), Version-23.0.
Results: A total of 101 type 2 medicated diabetic cases were employed in this study. The mean age of the patients was 50.11±11.87 years. The females constituted the majority 61 (60.6%). The average duration of diabetes of the participants was 8.46±6.12 years. A statistically significant association between HDL levels and the varying duration of type2 diabetes was observed (p=0.000) while the association between cholesterol, LDL, and triglycerides levels with varying duration of diabetes was not found statistically significant (P>0.05).
Conclusions: This study investigated a significant association between HDL levels and the varying duration of type2 diabetes while the association between cholesterol, LDL, and triglycerides levels with varying duration of diabetes was not found statistically significant.
Metrics
References
Afsana F, Habib SH, Wahab N, Huda MK, Sayeed MA, Ali L. Dyslipidemia and cardiovascular risk factors in Bangladeshi type 2 diabetic patients. BMC Public Health. 2019;19:301.
Islam S, Majumder AK, Akhter T, et al. Prevalence of dyslipidemia and associated factors in type 2 diabetic patients in Bangladesh. Diabetes Metab Syndr Obes. 2021;14:3495–504.
Hussain A, Zafar Iqbal M, Hoque S, et al. Serum Fasting lipid profile and glycemic control in Bangladeshi patients with T2DM. PLOS Glob Public Health. 2022;2:e0000689.
Analava M, Bhattacharya D, Reys. Dietary influence on type 2 diabetes (NIDDM). J Hum Ecol. 2007;21:139–47. DOI: https://doi.org/10.1080/09709274.2007.11905964
Goldfine and Beckman. Life and death in Denmark: lessons about diabetes and coronary heart disease. Circulation. 2008;117:1914–7. DOI: https://doi.org/10.1161/CIRCULATIONAHA.108.767681
Kunsisto J, Mykknen L, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes. 1994;43:960–7. DOI: https://doi.org/10.2337/diabetes.43.8.960
Mozaffarian D, Martijn B, Alberto A, Mer J. Trans fatty acids and cardiovascular diseases. N Engl J Med. 2006;354:1601–13. DOI: https://doi.org/10.1056/NEJMra054035
Ronald M, Krauss M. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care. 2004;27:1496–504. DOI: https://doi.org/10.2337/diacare.27.6.1496
Azad Khan AK, Hussain A, Holmboe-Ottesen G, et al. Lipid profile abnormalities in rural Bangladeshi adults with diabetes. Int J Environ Res Public Health. 2018;15(9):1944. DOI: https://doi.org/10.3390/ijerph15091944
Rahman T, Islam S, Ahmed T. Trends in lipid profiles among type 2 diabetes patients in Bangladesh. Front Endocrinol (Lausanne). 2021;12:663789.
Ali N, Akram R, Islam F, Karim MR, Alam F, Haque T. Association between lipid profiles and glycemic control in type 2 diabetes patients. PLoS One. 2020;15(5):e0234044.
Zaman MM, Rahman MM, Karim MN, Chowdhury SR, et al. The burden of cardiovascular disease associated with diabetes in Bangladesh. BMJ Open Diabetes Res Care. 2019;7:e000634.
Rai SK, Rai R, Mishra R, Shrestha B. Lipid profile abnormalities in type 2 diabetes mellitus patients in a tertiary care hospital in Nepal. J Diabetes Res. 2022;2022:756872.
Nesto RW. Lipid management in patients with type 2 diabetes. Am J Med. 2003;115(8A):29S–34S.
Goldberg IJ. Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001;86(3):965–71. DOI: https://doi.org/10.1210/jc.86.3.965
Rahman MM, Hasan MZ, Akter S. Dyslipidemia among patients with type 2 diabetes in Bangladesh: current prevalence and risk factors. Diabetes Metab Syndr Clin Res Rev. 2021;15(6):102274.
Akter S, Rahman MM, Abe SK, Sultana P. Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey. Bull World Health Organ. 2020;98(4):217–27.
Islam MT, Khan MAR, Saha SK. Dyslipidemia and its correlates in type 2 diabetes mellitus: a study from Bangladesh. Diabetes Metab Syndr Clin Res Rev. 2022;16(6):102386.
Ahmad S, Islam SMS, Hossain MA. Lipid abnormalities in type 2 diabetes mellitus: evidence from South Asia. Int J Diabetes Dev Ctries. 2021;41(2):203–10.
Taskinen MR. Diabetic dyslipidemia: from basic research to clinical practice. Diabetologia. 2002;45(6):733–49. DOI: https://doi.org/10.1007/s00125-003-1111-y